Get the Stockscreener App
3.43
3.11%
-0.11
After Hours:
3.43
Sight Sciences Inc stock is traded at $3.43, with a volume of 96,827.
It is down -3.11% in the last 24 hours and down -18.53% over the past month.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
See More
Previous Close:
$3.54
Open:
$3.47
24h Volume:
96,827
Relative Volume:
0.76
Market Cap:
$179.62M
Revenue:
$81.06M
Net Income/Loss:
$-55.55M
P/E Ratio:
-3.0088
EPS:
-1.14
Net Cash Flow:
$-47.98M
1W Performance:
-7.05%
1M Performance:
-18.53%
6M Performance:
+27.51%
1Y Performance:
-46.66%
1-Day Range:
$3.43
$3.54
1-Week Range:
$3.43
$3.74
52-Week Range:
$2.03
$6.82
Sight Sciences Inc Stock (SGHT) Company Profile
Name
Sight Sciences Inc
Sector
Industry
Phone
(415) 889-0550
Address
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
3.43 | 185.38M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
133.31 | 233.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
98.14 | 145.30B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
368.57 | 141.92B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.30 | 122.80B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
75.27 | 43.83B | 5.69B | 1.41B | 577.90M | 6.95 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-25 | Upgrade | Lake Street | Hold → Buy |
| Dec-06-24 | Initiated | UBS | Buy |
| Nov-04-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-21-24 | Initiated | Lake Street | Buy |
| Sep-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-12-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-23 | Upgrade | Stifel | Hold → Buy |
| Oct-04-22 | Initiated | Needham | Hold |
| Jul-26-22 | Initiated | Stifel | Hold |
| Feb-03-22 | Initiated | William Blair | Outperform |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Sight Sciences Inc Stock (SGHT) Latest News
Can you recover from losses in Sight Sciences Inc.Analyst Upgrade & Smart Allocation Stock Tips - newser.com
Palumbo Wealth Management LLC Invests $328,000 in Sight Sciences, Inc. $SGHT - MarketBeat
Using data filters to optimize entry into Sight Sciences Inc.July 2025 Breakouts & Daily Volume Surge Signals - newser.com
Using AI based signals to follow Sight Sciences Inc.Market Performance Report & Weekly Stock Performance Updates - newser.com
What indicators show strength in Sight Sciences Inc.Weekly Trade Review & AI Driven Price Predictions - newser.com
What does recent volatility data suggest for Sight Sciences Inc.July 2025 Big Picture & Risk Managed Investment Entry Signals - newser.com
Acadian Asset Management LLC Has $1.03 Million Holdings in Sight Sciences, Inc. $SGHT - MarketBeat
What’s next for Sight Sciences Inc. stock price2025 Trade Ideas & Weekly Setup with ROI Potential - newser.com
Custom strategy builders for tracking Sight Sciences Inc.2025 Trading Volume Trends & Entry Point Confirmation Signals - newser.com
What data driven models say about Sight Sciences Inc.’s futureMarket Performance Recap & Advanced Technical Signal Analysis - newser.com
Chart based analysis of Sight Sciences Inc. trendsFed Meeting & Safe Capital Growth Stock Tips - newser.com
Kck Ltd. Buys New Shares in Sight Sciences, Inc. $SGHT - MarketBeat
Aug Drivers: Will Sight Sciences Inc. stock recover after earningsJuly 2025 Fed Impact & Reliable Volume Spike Trade Alerts - khodrobank.com
Gainers Report: Is Sight Sciences Inc stock a value trapTrade Performance Summary & Fast Momentum Entry Tips - khodrobank.com
Sentiment analysis tools applied to Sight Sciences Inc.Portfolio Update Summary & Consistent Profit Trading Strategies - newser.com
Technical analysis overview for Sight Sciences Inc. stockJuly 2025 Breakouts & Long-Term Safe Investment Ideas - newser.com
Will a bounce in Sight Sciences Inc. offer an exitSwing Trade & Stock Market Timing Techniques - newser.com
SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits - sharewise.com
Using data models to predict Sight Sciences Inc. stock movementJuly 2025 Action & Community Consensus Stock Picks - newser.com
Published on: 2025-09-18 23:06:26 - خودرو بانک
News impact scoring models applied to Sight Sciences Inc.Insider Buying & Stock Portfolio Risk Control - newser.com
Published on: 2025-09-18 20:07:20 - خودرو بانک
Sight Sciences’ OMNI system shows strong results in glaucoma treatment By Investing.com - Investing.com Nigeria
Sight Sciences (NASDAQ:SGHT) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Identifying reversal signals in Sight Sciences Inc.Dip Buying & Long-Term Capital Growth Strategies - newser.com
Sight Sciences reports positive data for Omni surgical system - MassDevice
Sight Sciences Inc. stock momentum explainedJuly 2025 News Drivers & Proven Capital Preservation Tips - newser.com
Sight Sciences’ OMNI system shows strong results in glaucoma treatment - Investing.com
Sight Sciences, Inc. Reports Positive Meta-Analysis Results for OMNI Surgical System in Treating Open-Angle Glaucoma - Quiver Quantitative
Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use - GlobeNewswire
89% Treatment Success: Sight Sciences' OMNI System Proves Superior for Glaucoma in Major Meta-Analysis - Stock Titan
What the charts say about Sight Sciences Inc. todayJuly 2025 Summary & Free Safe Entry Trade Signal Reports - newser.com
Sight Sciences’ Earnings Call: Balancing Growth and Challenges - MSN
Activity Recap: Will Sight Sciences Inc stock recover after earningsJuly 2025 Trends & Risk Controlled Swing Trade Alerts - خودرو بانک
FOMO Trade: How does MLACR perform in inflationary periodsJuly 2025 Levels & Real-Time Market Sentiment Alerts - خودرو بانک
Retail Trends: Will Sight Sciences Inc outperform tech stocks2025 Stock Rankings & Fast Entry Momentum Alerts - خودرو بانک
Using Bollinger Bands to evaluate Sight Sciences Inc.Inflation Watch & Low Volatility Stock Recommendations - newser.com
Insider Sell: How cyclical is CrossAmerica Partners LP Limited Partnership’s revenue streamLong Setup & Long-Term Safe Investment Plans - خودرو بانک
Profit Recap: Can Sight Sciences Inc be recession proofJuly 2025 Gainers & Free Community Consensus Stock Picks - khodrobank.com
Aug Update: Is Sight Sciences Inc in a consolidation phase2025 Pullback Review & Consistent Income Trade Recommendations - خودرو بانک
Volatility Watch: Is Sight Sciences Inc. stock a value trap2025 Market Overview & Daily Market Momentum Tracking - khodrobank.com
Sight Sciences Inc Stock (SGHT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.04%
1.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):